{"id":"nvp","safety":{"commonSideEffects":[{"rate":"15-20","effect":"Rash"},{"rate":"0.1-0.3","effect":"Stevens-Johnson syndrome"},{"rate":"5-10","effect":"Hepatotoxicity"},{"rate":"10-15","effect":"Nausea"},{"rate":"5-10","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL4567342","moleculeType":"Unknown","molecularWeight":"431.56"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"NVP binds directly to HIV reverse transcriptase and inhibits its enzymatic activity, preventing the conversion of viral RNA into DNA and thus blocking HIV replication. It is used as part of combination antiretroviral therapy (cART) in HIV-infected patients. The drug has been a cornerstone of HIV treatment regimens, particularly in resource-limited settings.","oneSentence":"NVP is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV reverse transcriptase to prevent viral replication.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:43.224Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"HIV-1 infection as part of combination antiretroviral therapy"}]},"trialDetails":[{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT06337032","phase":"PHASE4","title":"A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments","status":"RECRUITING","sponsor":"Gilead Sciences","startDate":"2024-08-27","conditions":"HIV-1-infection","enrollment":350},{"nctId":"NCT05393193","phase":"PHASE4","title":"POC HIV Testing and Early DTG Use for Infants","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2022-07-04","conditions":"HIV","enrollment":900},{"nctId":"NCT02369406","phase":"PHASE2, PHASE3","title":"Early Infant HIV Treatment in Botswana","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harvard School of Public Health (HSPH)","startDate":"2015-05-04","conditions":"HIV, Pediatric AIDS","enrollment":67},{"nctId":"NCT04504331","phase":"PHASE1","title":"Study of Infigratinib in Combination With Tamoxifen in Hormone Receptor Positive, HER2 Negative, FGFR Altered Advanced Breast Cancer","status":"TERMINATED","sponsor":"Jennifer Lee Caswell-Jin","startDate":"2020-10-13","conditions":"Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer","enrollment":4},{"nctId":"NCT06001840","phase":"NA","title":"Promotion and Mitigation Factors Leading to Illegal Tobacco Purchases","status":"COMPLETED","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2024-01-04","conditions":"Cigarette Smoking, Nicotine Vaping","enrollment":65},{"nctId":"NCT06601322","phase":"NA","title":"Functional Outcomes in CondUction System Pacing and Right Ventricular Synchrony (FOCUS-Right)","status":"RECRUITING","sponsor":"Virginia Commonwealth University","startDate":"2024-08-23","conditions":"Left Branch Bundle Block, RV - Right Ventricular Abnormality","enrollment":20},{"nctId":"NCT07161050","phase":"NA","title":"Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing","status":"RECRUITING","sponsor":"Virginia Polytechnic Institute and State University","startDate":"2025-12-01","conditions":"Cigarette Smoking, E-cigarette Use","enrollment":70},{"nctId":"NCT06566274","phase":"NA","title":"Thumbtack Needle in the Treatment of NVP","status":"RECRUITING","sponsor":"Dongmei Huang","startDate":"2024-10-01","conditions":"Nausea and Vomiting in Pregnancy (NVP)","enrollment":320},{"nctId":"NCT05544929","phase":"PHASE1","title":"A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers","status":"ACTIVE_NOT_RECRUITING","sponsor":"Novartis Pharmaceuticals","startDate":"2022-10-26","conditions":"Carcinoma, Non-Small-Cell Lung, Cutaneous Melanoma, Carcinoma, Renal Cell","enrollment":126},{"nctId":"NCT02302547","phase":"PHASE3","title":"Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2014-12","conditions":"HIV","enrollment":224},{"nctId":"NCT07129473","phase":"PHASE2","title":"Hyperemesis Gravidarum Risk Reduction With Metformin","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-01","conditions":"Hyperemesis Gravidarum","enrollment":224},{"nctId":"NCT00042289","phase":"","title":"Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-06-09","conditions":"HIV Infections","enrollment":1578},{"nctId":"NCT04338399","phase":"PHASE3","title":"The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC","status":"COMPLETED","sponsor":"Adlai Nortye Biopharma Co., Ltd.","startDate":"2020-12-12","conditions":"Head and Neck Cancer","enrollment":487},{"nctId":"NCT05502341","phase":"PHASE2, PHASE3","title":"Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2022-08-16","conditions":"HIV-1-infection","enrollment":689},{"nctId":"NCT02140255","phase":"PHASE1, PHASE2","title":"Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-01-23","conditions":"HIV Infection","enrollment":1120},{"nctId":"NCT03194165","phase":"","title":"Population Pharmacokinetics of Antiretroviral in Children","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-16","conditions":"Minor Patient Treated by One or More Antiretroviral and for Which a Blood Test Has Been Performed","enrollment":65},{"nctId":"NCT07080138","phase":"","title":"Research on the Psychological Status of Patients With HIV-1 Infection","status":"NOT_YET_RECRUITING","sponsor":"Shanxi Bethune Hospital","startDate":"2025-08-01","conditions":"HIV-1-infection, Anxiety Depression","enrollment":500},{"nctId":"NCT02285114","phase":"PHASE2, PHASE3","title":"Study To Evaluate Emtricitabine/Tenofovir Alafenamide (F/TAF) in Human Immunodeficiency Virus 1 (HIV-1) Infected Children and Adolescents Virologically Suppressed on a 2-Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (2-NRTI)-Containing Regimen","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2015-01-20","conditions":"HIV-1","enrollment":41},{"nctId":"NCT04975958","phase":"PHASE1","title":"Double/Triple Combinations of AN2025, AN0025 and Atezolizumab in Advanced Solid Tumors","status":"COMPLETED","sponsor":"Adlai Nortye Biopharma Co., Ltd.","startDate":"2021-09-07","conditions":"Locally Advanced Solid Tumor","enrollment":47},{"nctId":"NCT07014189","phase":"PHASE4","title":"Nevirapine / Lamivudine for HIV Maintenance Therapy","status":"COMPLETED","sponsor":"Cantonal Hospital of St. Gallen","startDate":"2019-04-12","conditions":"HIV Infection, Antiretroviral Treatment, Maintenance Therapy","enrollment":201},{"nctId":"NCT00146380","phase":"PHASE2","title":"A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During Breastfeeding","status":"COMPLETED","sponsor":"Centers for Disease Control and Prevention","startDate":"2003-07","conditions":"HIV Infections","enrollment":520},{"nctId":"NCT00476606","phase":"","title":"A Prospective Cohort of Children With HIV Infection","status":"COMPLETED","sponsor":"The HIV Netherlands Australia Thailand Research Collaboration","startDate":"2003-03","conditions":"HIV Infections","enrollment":500},{"nctId":"NCT06841029","phase":"","title":"Management of Nausea and Vomiting in Pregnancy and Hyperemesis Gravidarum: Evaluation of Clinical Practices in Five Maternity Hospitals in Île-de-France","status":"COMPLETED","sponsor":"Centre Hospitalier de Saint-Denis","startDate":"2023-10-15","conditions":"He Study Focuses on Evaluating Current Clinical Practices Rather Than Testing an Intervention","enrollment":117},{"nctId":"NCT00144261","phase":"PHASE4","title":"An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ Subjects","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-11-01","conditions":"HIV Infections, Metabolism, Lipids","enrollment":15},{"nctId":"NCT00167674","phase":"PHASE2","title":"ARVs to Prevent Breastmilk HIV:Viral and Immune Responses","status":"COMPLETED","sponsor":"University of Washington","startDate":"2003-11-03","conditions":"HIV Infections","enrollment":58},{"nctId":"NCT06761066","phase":"NA","title":"Efficacy and Safety of NVP-NK4146 in Patients with Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease","status":"NOT_YET_RECRUITING","sponsor":"NVP Healthcare","startDate":"2025-04-01","conditions":"Alzheimer Disease","enrollment":60},{"nctId":"NCT02397096","phase":"PHASE3","title":"Safety and Efficacy of a Switch to Doravirine, Tenofovir, Lamivudine (MK-1439A) in Human Immunodeficiency Virus (HIV-1)-Infected Participants Virologically Suppressed on an Anti-retroviral Regimen in Combination With Two Nucleoside Reverse Transcriptase Inhibitors (MK-1439A-024)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-06-09","conditions":"HIV-1 Infection","enrollment":673},{"nctId":"NCT02113878","phase":"PHASE1","title":"Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2014-09-29","conditions":"Carcinoma, Squamous Cell of Head and Neck, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Hypopharyngeal Cancer","enrollment":23},{"nctId":"NCT01717885","phase":"","title":"Antimalarial Pharmacology in Children and Pregnant Women in Uganda","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2012-08","conditions":"Malaria, HIV","enrollment":473},{"nctId":"NCT06059794","phase":"","title":"Anxiety in Relation to Nausea and Vomiting in Pregnancy","status":"COMPLETED","sponsor":"Ain Shams Maternity Hospital","startDate":"2023-01-01","conditions":"Nausea Gravidarum, Anxiety","enrollment":102},{"nctId":"NCT02159066","phase":"PHASE2","title":"LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma","status":"COMPLETED","sponsor":"Pfizer","startDate":"2014-07-23","conditions":"Melanoma","enrollment":158},{"nctId":"NCT00144248","phase":"PHASE4","title":"A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2004-06-25","conditions":"HIV Infections, Hepatic Insufficiency","enrollment":51},{"nctId":"NCT04182750","phase":"NA","title":"Promoting Safe Medication Use in Pregnancy in the Era of Real-World Data - The SafeStart Study","status":"COMPLETED","sponsor":"Hedvig Marie Egeland Nordeng","startDate":"2018-02-06","conditions":"Pregnancy Early, Emesis, Medication Adherence","enrollment":369},{"nctId":"NCT04719286","phase":"NA","title":"MinSafeStart - Decision Aid Tool for Better Treatment of Nausea and Vomiting During Pregnancy","status":"COMPLETED","sponsor":"Hedvig Marie Egeland Nordeng","startDate":"2019-09-02","conditions":"Hyperemesis Gravidarum, Emesis, Emesis Pregnancy","enrollment":217},{"nctId":"NCT03537196","phase":"PHASE4","title":"DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)","status":"COMPLETED","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2018-11-13","conditions":"Hepatitis C, Drug Use, Viral Hepatitis C","enrollment":979},{"nctId":"NCT01397877","phase":"PHASE2","title":"GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer","status":"COMPLETED","sponsor":"ARCAGY/ GINECO GROUP","startDate":"2011-12","conditions":"Endometrial Cancer","enrollment":24},{"nctId":"NCT01789879","phase":"PHASE2","title":"A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2014-03-04","conditions":"HIV, Contraception","enrollment":60},{"nctId":"NCT02340780","phase":"PHASE2","title":"Buparlisib in Patients With Relapsed and Refractory Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2015-04-27","conditions":"Chronic Lymphocytic Leukemia","enrollment":14},{"nctId":"NCT02273219","phase":"PHASE1","title":"Trial of AEB071 in Combination With BYL719 in Patients With Melanoma","status":"COMPLETED","sponsor":"Columbia University","startDate":"2014-11-19","conditions":"Uveal Melanoma","enrollment":30},{"nctId":"NCT01591421","phase":"PHASE1, PHASE2","title":"P13Kinase Inhibitor BKM120 in Combination With Panitumumab in Metastatic/Advanced RAS-Wild Type Colorectal Cancer.","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2012-09-06","conditions":"Metastatic Colorectal Cancer","enrollment":22},{"nctId":"NCT01971489","phase":"PHASE1","title":"Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors","status":"WITHDRAWN","sponsor":"Roswell Park Cancer Institute","startDate":"2015-09","conditions":"Adult Solid Neoplasm, Recurrent Non-Small Cell Lung Carcinoma, Stage IIIA Non-Small Cell Lung Cancer","enrollment":""},{"nctId":"NCT03916328","phase":"PHASE4","title":"BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study","status":"UNKNOWN","sponsor":"MU-JHU CARE","startDate":"2019-12-03","conditions":"Bone Loss","enrollment":330},{"nctId":"NCT01570296","phase":"PHASE1","title":"A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR","status":"COMPLETED","sponsor":"National Cancer Centre, Singapore","startDate":"2011-10-03","conditions":"Non-Small Cell Lung Cancer, Solid Tumors","enrollment":38},{"nctId":"NCT00074412","phase":"PHASE3","title":"Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2007-01","conditions":"HIV Infections","enrollment":2026},{"nctId":"NCT03785691","phase":"PHASE2","title":"Validating the Effect og Ondansetron and Mirtazapine in Treating Hyperemesis Gravidarum","status":"TERMINATED","sponsor":"Nordsjaellands Hospital","startDate":"2019-03-01","conditions":"Hyperemesis Gravidarum, Nausea Gravidarum, Vomiting of Pregnancy","enrollment":58},{"nctId":"NCT02756247","phase":"PHASE1","title":"A Clinical Trial of Buparlisib and Ibrutinib in Lymphoma","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2016-05-09","conditions":"Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma","enrollment":37},{"nctId":"NCT02712801","phase":"PHASE4","title":"Antiretroviral Regime for Viral Eradication in Newborns","status":"COMPLETED","sponsor":"National Center for Women and Children's Health, China CDC","startDate":"2016-04","conditions":"HIV/AIDS and Infections","enrollment":600},{"nctId":"NCT02117817","phase":"PHASE1","title":"Phase I BKM120/Abraxane in Solid Tumors, Expansion Phase Recurrent Endometrial or Ovarian Cancer","status":"WITHDRAWN","sponsor":"Rutgers, The State University of New Jersey","startDate":"2015-02","conditions":"Ovarian Cancer, Endometrial Cancer, Recurrent Ovarian Cancer","enrollment":""},{"nctId":"NCT01540253","phase":"PHASE1","title":"PI3K Inhibitor BKM120 and Docetaxel in Treating Patients With Advanced Solid Tumor That is Locally Advanced, Cannot Be Removed By Surgery, or Metastatic","status":"COMPLETED","sponsor":"Roswell Park Cancer Institute","startDate":"2012-05","conditions":"Unspecified Adult Solid Tumor, Protocol Specific","enrollment":38},{"nctId":"NCT03088410","phase":"PHASE4","title":"Study of HIV-Infected and Uninfected Pregnant Woman/Child Dyads in Gaborone, Botswana","status":"COMPLETED","sponsor":"Ann & Robert H Lurie Children's Hospital of Chicago","startDate":"2016-08-22","conditions":"HIV, Insulin Sensitivity, Diabetes Mellitus","enrollment":495},{"nctId":"NCT02049541","phase":"PHASE1","title":"Study of BKM120 & Rituximab in Patients With Relapsed or Refractory Indolent B-Cell Lymphoma","status":"COMPLETED","sponsor":"Kami Maddocks, MD","startDate":"2014-07-21","conditions":"Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Nodal Marginal Zone B-cell Lymphoma, Recurrent Grade 1 Follicular Lymphoma","enrollment":18},{"nctId":"NCT02220855","phase":"PHASE2","title":"A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas","status":"COMPLETED","sponsor":"Patrick Joseph Loehrer Sr.","startDate":"2014-10-01","conditions":"Thymoma","enrollment":14},{"nctId":"NCT05017558","phase":"","title":"Evaluation of Measurement of Maternal Viral Load at Delivery to Optimise Post-natal Prophylaxis of HIV-exposed Newborns","status":"UNKNOWN","sponsor":"ANRS, Emerging Infectious Diseases","startDate":"2022-03","conditions":"Mother to Child HIV Transmission","enrollment":100},{"nctId":"NCT01061151","phase":"PHASE3","title":"Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-03-01","conditions":"HIV Infections","enrollment":3747},{"nctId":"NCT02000882","phase":"PHASE2","title":"STAR Cape+BKM120 MBC With Brain Met","status":"COMPLETED","sponsor":"US Oncology Research","startDate":"2014-05-29","conditions":"Brain Metastases, Breast Cancer, Metastatic Breast Cancer","enrollment":10},{"nctId":"NCT00672412","phase":"PHASE1, PHASE2","title":"Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in Thailand","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-10","conditions":"HIV Infections","enrollment":42},{"nctId":"NCT00260078","phase":"PHASE1, PHASE2","title":"Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-02","conditions":"HIV Infections","enrollment":75},{"nctId":"NCT00109590","phase":"PHASE2","title":"Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-06","conditions":"HIV Infections","enrollment":175},{"nctId":"NCT00074581","phase":"PHASE3","title":"Preventing Sexual Transmission of HIV With Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-02","conditions":"HIV Infections","enrollment":3526},{"nctId":"NCT00039741","phase":"PHASE2, PHASE3","title":"Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-08","conditions":"HIV Infections","enrollment":266},{"nctId":"NCT00001045","phase":"PHASE2","title":"Comparison of Three Anti-HIV Drug Combinations in HIV-Infected Patients With No Symptoms of the Disease","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00006396","phase":"PHASE3","title":"Effectiveness of AZT and Nevirapine in Preventing HIV Transmission From Ugandan Mothers to Their Newborns","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1500},{"nctId":"NCT00000872","phase":"PHASE2","title":"Treatment With Combinations of Several Antiviral Drugs in Infants and Young Children With HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":55},{"nctId":"NCT00001091","phase":"PHASE1","title":"Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":200},{"nctId":"NCT00001083","phase":"PHASE2","title":"Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":240},{"nctId":"NCT00099632","phase":"PHASE2","title":"Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-03","conditions":"HIV Infections","enrollment":484},{"nctId":"NCT00000781","phase":"PHASE2","title":"A Randomized, Double-Blind, Four-Arm Study Comparing Combination Nucleoside, Alternating Nucleoside, and Triple-Drug Therapy for the Treatment of Advanced HIV Disease (CD4 <= 50/mm3)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":1292},{"nctId":"NCT00001095","phase":"PHASE2","title":"A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":94},{"nctId":"NCT00000808","phase":"PHASE1","title":"A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":49},{"nctId":"NCT00000770","phase":"PHASE2","title":"A Comparative Study of a Combination of Zidovudine, Didanosine, and Double-Blinded Nevirapine Versus a Combination of Zidovudine and Didanosine","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":400},{"nctId":"NCT00102960","phase":"PHASE3","title":"Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2005-07","conditions":"HIV Infections","enrollment":377},{"nctId":"NCT00312091","phase":"PHASE1, PHASE2","title":"Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-12","conditions":"HIV Infections","enrollment":44},{"nctId":"NCT00270296","phase":"PHASE2","title":"Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-06","conditions":"HIV Infections","enrollment":730},{"nctId":"NCT00006279","phase":"PHASE1","title":"The Safety of Nevirapine When Given to Breast-Feeding Babies From Birth to Age 6 Months","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":75},{"nctId":"NCT00017719","phase":"PHASE3","title":"Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2002-05","conditions":"HIV Infections, Pregnancy","enrollment":440},{"nctId":"NCT00344461","phase":"PHASE4","title":"A Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and Nevirapine","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2004-03","conditions":"HIV","enrollment":54},{"nctId":"NCT00001135","phase":"PHASE3","title":"A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":2009},{"nctId":"NCT00001108","phase":"PHASE1","title":"A Study of the Safety and Effectiveness of Treating Advanced AIDS Patients Between Ages 4 and 22 With 7 Drugs, Some at Higher Than Usual Doses","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":6},{"nctId":"NCT00021671","phase":"PHASE3","title":"Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":3720},{"nctId":"NCT00004855","phase":"NA","title":"Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":55},{"nctId":"NCT00087464","phase":"NA","title":"Three Month Course of Anti-HIV Medications for People Recently Infected With HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00000942","phase":"PHASE3","title":"A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":1244},{"nctId":"NCT00000924","phase":"PHASE2","title":"A Study to Compare Two Different Anti-HIV Drug Regimens","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT00000902","phase":"PHASE1","title":"A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":217},{"nctId":"NCT00000896","phase":"NA","title":"A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT00000895","phase":"NA","title":"A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"Mycobacterium Avium-intracellulare Infection, HIV Infections","enrollment":85},{"nctId":"NCT00000869","phase":"PHASE3","title":"A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Pregnancy","enrollment":2009},{"nctId":"NCT00000814","phase":"PHASE1","title":"A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":390},{"nctId":"NCT01511237","phase":"PHASE3","title":"Perinatal Antiretroviral Intensification for PMTCT of HIV in Late Comers","status":"COMPLETED","sponsor":"Institut de Recherche pour le Developpement","startDate":"2011-12","conditions":"HIV Infections","enrollment":379},{"nctId":"NCT01435018","phase":"PHASE3","title":"Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS","status":"COMPLETED","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2013-10-01","conditions":"HIV-1 Infection","enrollment":334},{"nctId":"NCT01806649","phase":"PHASE2","title":"BKM120 in Esophageal Squamous Cell Carcinoma After Failure of First Line Chemotherapy","status":"TERMINATED","sponsor":"Prince of Songkla University","startDate":"2013-07-01","conditions":"Esophageal Cancer","enrollment":5},{"nctId":"NCT01816984","phase":"PHASE1, PHASE2","title":"PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2013-05","conditions":"Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Salivary Gland Cancer","enrollment":12},{"nctId":"NCT03631732","phase":"PHASE3","title":"Study to Evaluate Switching From a Regimen of Two Nucleos(t)Ide Reverse Transcriptase Inhibitors (NRTI) Plus a Third Agent to a Fixed Dose Combination (FDC) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF), in Virologically-Suppressed, HIV-1 Infected African American Participants","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2018-08-28","conditions":"HIV-1 Infection","enrollment":496},{"nctId":"NCT02383849","phase":"","title":"IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight Infants","status":"COMPLETED","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2015-08-04","conditions":"Low-Birth-Weight Infant, Tuberculosis, HIV","enrollment":124},{"nctId":"NCT00872872","phase":"NA","title":"Nevirapine Clearance After Short-term Highly Active Antiretroviral Therapy (HAART) for Prevention of Mother to Child Transmission of HIV (PMTCT)","status":"COMPLETED","sponsor":"Thai Red Cross AIDS Research Centre","startDate":"2008-05","conditions":"NVP Plasma Level, NVP Related Mutation, 3TC Related Mutation","enrollment":30},{"nctId":"NCT01551030","phase":"PHASE2","title":"Buparlisib in Metastatic Transitional Cell Carcinoma of the Urothelium","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-03","conditions":"Metastatic Transitional Cell Carcinoma of the Urothelium","enrollment":19},{"nctId":"NCT01760525","phase":"PHASE1","title":"A Phase I Dose Escalation Study of CGM097 in Adult Patients With Selected Advanced Solid Tumors","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-03-20","conditions":"Solid Tumor With p53 Wild Type Status","enrollment":51},{"nctId":"NCT02104700","phase":"PHASE2, PHASE3","title":"Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir","status":"COMPLETED","sponsor":"Philip Grant","startDate":"2014-04","conditions":"HIV","enrollment":150},{"nctId":"NCT01623349","phase":"PHASE1","title":"Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2012-09","conditions":"Ovarian Cancer, Breast Cancer","enrollment":118}],"_emaApprovals":[],"_faersSignals":[{"count":4,"reaction":"NEUROPATHY PERIPHERAL"},{"count":3,"reaction":"FANCONI SYNDROME ACQUIRED"},{"count":3,"reaction":"NEPHROPATHY TOXIC"},{"count":2,"reaction":"ACUTE KIDNEY INJURY"},{"count":2,"reaction":"ANAEMIA"},{"count":2,"reaction":"CONFUSIONAL STATE"},{"count":2,"reaction":"DRUG INEFFECTIVE"},{"count":2,"reaction":"DUODENITIS"},{"count":2,"reaction":"GASTRITIS"},{"count":2,"reaction":"PROTEINURIA"}],"_approvalHistory":[],"publicationCount":3533,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Nevirapine"],"phase":"phase_3","status":"active","brandName":"NVP","genericName":"NVP","companyName":"Johns Hopkins Bloomberg School of Public Health","companyId":"johns-hopkins-bloomberg-school-of-public-health","modality":"Small molecule","firstApprovalDate":"","aiSummary":"NVP is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that blocks HIV reverse transcriptase to prevent viral replication. Used for HIV-1 infection as part of combination antiretroviral therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}